Phase 3 Clinical Project of Pegylated Recombinant Human Coagulation Factor VIII-Fc Fusion Protein

Clinical trial NCT06142552 · RECRUITING

Trial details

NCT number: NCT06142552
Sponsor: Hangzhou Gensciences Biopharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Severe Hemophilia A

Start date: 2023-12-27
Primary completion: 2026-01-15
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.